keyword
Keywords Inflammatory markers,polycysti...

Inflammatory markers,polycystic ovary syndrome

https://read.qxmd.com/read/38646104/effect-of-calorie-restriction-and-intermittent-fasting-on-glucose-homeostasis-lipid-profile-inflammatory-and-hormonal-markers-in-patients-with-polycystic-ovary-syndrome-a-systematic-review
#1
Anam S Kalsekar, Dana N Abdelrahim, MoezAlIslam E Faris
BACKGROUND AND OBJECTIVE: Polycystic ovary syndrome (PCOS) is a complex hormonal disorder that leads to ovarian cysts, irregular ovulation, and hormonal swings in women. It is a complex and heterogeneous condition that affects 4 to 20% of women of reproductive age worldwide and relates to reproductive, metabolic, and psychosocial dysfunction. Dietary and lifestyle modifications have been proposed to play a central role in the management of PCOS. This study aimed to provide a comprehensive systemic overview of the existing literature on the effects of intermittent fasting (IF) and calorie restriction (CR) regimens on disease markers of PCOS...
2024: Frontiers in Nutrition
https://read.qxmd.com/read/38604038/a-cross-talk-study-on-sitagliptin-mediated-reclamation-on-tgf-%C3%AE-signalling-dpp-4-mir-29a-and-mir-24-expression-in-pcos-rats-fed-with-high-fat-high-fructose-diet
#2
JOURNAL ARTICLE
Dipti Nanda, Anuradha Carani Venkatraman, Kalpana Kalaivanan
Polycystic Ovary Syndrome (PCOS) is a multifactorial reproductive, endocrine and metabolic disturbance which is very commonly observed in females of reproductive age group. The disease is still incurable however the use of synthetic drugs in combination with lifestyle is recommended. Accordingly, the present study was conducted to investigate the possible beneficial effects of sitagliptin on PCOS induced rats on control diet (CD)/high fat- high fructose diet (HFFD). PCOS was induced by giving testosterone propionate (TP) for 28 days to both the CD/HFFD rats and treated with STG i...
April 4, 2024: Tissue & Cell
https://read.qxmd.com/read/38603629/cellular-senescence-of-granulosa-cells-in-the-pathogenesis-of-polycystic-ovary-syndrome
#3
JOURNAL ARTICLE
Tsurugi Tanaka, Yoko Urata, Miyuki Harada, Chisato Kunitomi, Akari Kusamoto, Hiroshi Koike, Zixin Xu, Nanoka Sakaguchi, Chihiro Tsuchida, Airi Komura, Ayaka Teshima, Nozomi Takahashi, Osamu Wada-Hiraike, Yasushi Hirota, Yutaka Osuga
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, but its pathology has not been fully characterized and the optimal treatment strategy remains unclear. Cellular senescence is a permanent state of cell-cycle arrest that can be induced by multiple stresses. Senescent cells contribute to the pathogenesis of various diseases, owing to an alteration in secretory profile, termed 'senescence-associated secretory phenotype' (SASP), including with respect to pro-inflammatory cytokines...
April 11, 2024: Molecular Human Reproduction
https://read.qxmd.com/read/38596120/a-combination-of-gliclazide-and-metformin-attenuates-obesity-induced-polycystic-ovary-syndrome-in-female-wistar-rats
#4
JOURNAL ARTICLE
Anam Moazzam, Ammara Saleem, Shahid Shah, Liaqat Hussain, Mirza Muhammad Faran Ashraf Baig, Abdulrahman Alshammari, Norah A Albekairi, Muhammad Furqan Akhtar
Presently, it is known that the progression of obesity concomitantly leads to polycystic ovary syndrome and infertility. This study aimed to evaluate the potential effects of metformin (M; insulin secretagogues) and gliclazide (G; insulin sensitizer) alone and their combination at different doses to treat obesity-induced PCOS. High high-fat diet was given to all female Wistar rats for nine weeks to induce obesity except for the normal control group which received a normal chow diet. Estradiol valerate (0.8 mg/kg) was also given to all obese rats to induce polycystic ovarian syndrome...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38590945/activity-of-isoflavone-in-managing-polycystic-ovary-syndrome-symptoms-review
#5
REVIEW
Cut Raihanah, Sukrasno Sukrasno, Neng Fisheri Kurniati
Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress...
May 2024: Biomedical Reports
https://read.qxmd.com/read/38589892/mitigation-of-letrozole-induced-polycystic-ovarian-syndrome-associated-inflammatory-response-and-endocrinal-dysfunction-by-vitex-negundo-seeds
#6
JOURNAL ARTICLE
Tarun Kumar Kar, Sananda Sil, Angshita Ghosh, Ananya Barman, Sandip Chattopadhyay
BACKGROUND: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder in women that necessitates effective and safe treatment alternatives. This study aimed to evaluate the therapeutic efficacy of Vitex negundo seed in a letrozole-induced PCOS rat model. RESULTS: Findings of the present study demonstrated that administration of hydro-ethanolic extract of Vitex negundo (VNE) effectively restored endocrino-metabolic imbalances associated with PCOS, along with correction of antioxidant enzymes level, proinflammatory cytokines, and apoptotic bio-markers...
April 8, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38540173/mechanisms-and-target-parameters-in-relation-to-polycystic-ovary-syndrome-and-physical-exercise-focus-on-the-master-triad-of-hormonal-changes-oxidative-stress-and-inflammation
#7
REVIEW
Csanád Endre Lőrincz, Denise Börzsei, Alexandra Hoffmann, Csaba Varga, Renáta Szabó
Polycystic ovary syndrome (PCOS) is a common endocrine disorder among females of reproductive age with heterogeneous prevalence. It is well known that female reproductive competence depends on the dynamic regulation of the hypothalamic-pituitary-gonadal (HPG) axis; therefore, disruption of this highly regulated system leads to fertility problems. Among disruptors, both oxidative stress and inflammation contribute to an increased LH-FSH ratio and a consequent hyperandrogenism. Shifts in this bidirectional interplay between the neuroendocrine system and oxidative/inflammatory homeostasis result in the accumulation of reactive oxygen/nitrogen species and inflammatory markers as well as alterations in antioxidant defense mechanisms...
March 1, 2024: Biomedicines
https://read.qxmd.com/read/38404048/positive-effects-of-rutin-on-female-reproduction
#8
REVIEW
Alexander V Sirotkin
This article reviews the source and properties of rutin (vitamin P), its general physiological and medicinal effects and their mechanisms, but the main subject of it is the currently available knowledge concerning the character and mechanisms of action of rutin on female reproductive processes. The available data demonstrate the stimulatory action of rutin on female reproductive processes: it can promote ovarian follicles development and ovulation, ovarian cyclicity, and viability of ovarian cells. On the other hand, it can suppress ovarian cancer cell and tumour development by inhibition of cell proliferation and growth and activation of their apoptosis and death...
February 2024: Reproduction in Domestic Animals
https://read.qxmd.com/read/38347150/effects-of-aidiet-intervention-to-improve-diet-quality-immuno-metabolic-health-in-normal-and-overweight-pcos-girls-a-pilot-study
#9
JOURNAL ARTICLE
Małgorzata Mizgier, Barbara Więckowska, Dorota Formanowicz, Giovanni Lombardi, Alicja Brożek, Marcin Nowicki, Krzysztof Durkalec-Michalski, Witold Kędzia, Grażyna Jarząbek-Bielecka
This study was conducted in two groups of girls with PCOS (polycystic ovary syndrome) categorized as slim (group N) and overweight-to-obese (group Ov/Ob). The study's primary outcome was to assess the impact of a 12-week anti-inflammatory diet (AIDiet) intervention, without energy deficit, on daily diet quality improvement, evaluated according to the KIDMED index. The secondary outcome was improving inflammatory, redox, hormonal, and metabolic statuses. In the study, which was completed by 13 girls from the Ov/Ob group and 19 girls from the N group, a significant improvement in the mean KIDMED score was obtained...
February 12, 2024: Scientific Reports
https://read.qxmd.com/read/38219291/empirical-dietary-inflammatory-pattern-is-positively-associated-with-polycystic-ovary-syndrome-a-case-control-study
#10
JOURNAL ARTICLE
Elnaz Zirak Sharkesh, Seyed Ali Keshavarz, Leila Nazari, Behnood Abbasi
Polycystic ovary syndrome (PCOS), as the most common endocrine disorder in women of reproductive age, is influenced by various factors. Because there is evidence linking inflammation with chronic diseases, we hypothesized that there is a relationship between an empirical dietary inflammatory pattern score (EDIP) with odds of PCOS among the adult population. This case control study was conducted on Tehranian women in Iran. A total of 494 participants (203 women with PCOS in the case group and 291 healthy people in the control group), aged 18 to 45 years, were recruited for the study...
February 2024: Nutrition Research
https://read.qxmd.com/read/38215787/correlation-between-chronic-low-grade-inflammation-and-glucose-and-lipid-metabolism-indicators-in-polycystic-ovary-syndrome
#11
JOURNAL ARTICLE
Yan Zhou, Xia Wang, Siqi Guo, Ruiying Li, Ye Li, Ying Yu, Ting Liu
OBJECTIVE: The purpose of this study was to explore the correlation between inflammatory indicators and blood lipids and to further provide a theoretical basis for the diagnosis and treatment of clinical polycystic ovary syndrome (PCOS). METHODS: Whole-blood cell counts and hormone and blood lipid levels were measured in 110 patients with PCOS and 126 healthy women. The differences in the above levels and the correlation between inflammation and blood lipid levels in the two groups were determined, and classified according to BMI...
January 8, 2024: Gynecological Endocrinology
https://read.qxmd.com/read/38183697/troxerutin-dampened-hypothalamic-neuroinflammation-via-microglial-il-22-il-22r1-irf3-activation-in-dihydrotestosterone-induced-polycystic-ovary-syndrome-rats
#12
JOURNAL ARTICLE
Zixuan Gao, Huihui Tan, Xueli Song, Tao Zhuang, Renyu Kong, Yuying Wang, Xiaonan Yan, Ruiqin Yao
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common reproductive-endocrine condition in premenopausal women. Troxerutin, a common clinical anti-coagulant agent, was shown to work as a strong IL-22 boosting agent counteracting the hyperactivated gonadotrophin releasing hormone (GnRH) neurons and heightened GnRH release, the neuroendocrine origin of PCOS with unknown mechanism in rats. Exploring the off-label use of troxerutin medication for PCOS is thus sorely needed. METHODS: Serum IL-22 content and hypothalamic IL-22 protein were detected...
December 17, 2023: Phytomedicine
https://read.qxmd.com/read/38087363/the-association-between-systemic-immune-inflammation-index-and-in-vitro-fertilization-outcomes-in-women-with-polycystic-ovary-syndrome-a-cohort-study
#13
JOURNAL ARTICLE
Xin Li, Ting Luan, Yi Wei, Juan Zhang, JuanJuan Zhang, Chun Zhao, Xiufeng Ling
BACKGROUND: As a novel prognostic and inflammatory marker, the systemic immune-inflammation index (SII) has come to the foreground in recent years. SII may be used as an indicator reflecting the progressive inflammatory process in patients with polycystic ovary syndrome (PCOS). This study aimed to evaluate the correlation between SII and assisted reproductive outcomes in PCOS patients. RESULTS: A total of 966 women undergoing in vitro fertilization (IVF) procedure with PCOS were included in the study...
December 13, 2023: Journal of Ovarian Research
https://read.qxmd.com/read/38053704/idiopathic-intracranial-hypertension-associated-with-polycystic-ovarian-syndrome-sensorineural-hearing-loss-and-elevated-inflammatory-markers-that-lead-to-bilateral-blindness-a-case-report-with-literature-review
#14
Sara Zarei, Setareh Kamali, William Narinyan, Farnoush Nasouri, Sara Hassani, Abdul Mahmoud Ibrahim, Rojeen Zarei, Sadiq Altamimi
BACKGROUND: Pseudotumor cerebri (PTC) or idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure without hydrocephalus or mass lesion, with normal cerebrospinal fluid (CSF) studies and neuroimaging. The exact cause remains uncertain, but potential mechanisms include increased CSF production, impaired CSF absorption, cerebral edema, and abnormal cerebral venous pressure gradients. Patients may present with various accompanying symptoms such as unilateral or bilateral visual obscuration, pulsatile tinnitus, back pain, dizziness, neck pain, blurred vision, cognitive difficulties, radicular pain, and typically intermittent horizontal diplopia...
2023: Surgical Neurology International
https://read.qxmd.com/read/38041462/embryo-condition-media-collected-from-polycystic-ovary-syndrome-patients-with-abdominal-obesity-can-increase-the-decidualization-potential-of-healthy-endometrial-stromal-cells
#15
JOURNAL ARTICLE
Zohreh Shalchian, Saba Taheri, Maryam Hafezi, Tahereh Madani, Nahid Nasiri, Poopak Eftekhari Yazdi
BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrinological disorder associated with abdominal obesity (AO) and some reproductive complications including low pregnancy rate. Embryo-endometrium cross-talk has a key role in successful embryo implantation and subsequent normal pregnancy rate. The primary objective of this study is to evaluate the decidualization potential of endometrial stromal cells (ESCs) using the embryo condition media (ECM) collected from PCOS patients with AO, compared to ECM of those patients without AO...
November 7, 2023: International Journal of Fertility & Sterility
https://read.qxmd.com/read/37985173/sglt-2-inhibitors-enhance-the-effect-of-metformin-to-ameliorate-hormonal-changes-and-inflammatory-markers-in-a-rat-pcos-model
#16
JOURNAL ARTICLE
Manal Moustafa Mahmoud, Laila Ahmed Rashed, Somia Abdulatif Soliman, Safaa Mostafa Sayed, Omneya Kamel, Samaa Samir Kamar, Rania El Sayed Hussien
Polycystic ovary syndrome (PCOS) is a common endocrine, reproductive, and metabolic disorder affecting females. The management of PCOS is challenging and current interventions are not enough to deal with all consequences of this syndrome. We explored the beneficial effect of combined sodium glucose co transporter-2 inhibitor (SGLT-2i); (empagliflozin) and metformin on hormonal and metabolic parameters in an animal model of PCOS and insulin resistance (IR). Forty adult female Wistar rats divided into five groups: control, PCOS-IR, PCOS-IR treated with metformin, PCOS-IR treated with empagliflozin, and PCOS-IR treated with combined metformin and empagliflozin...
November 2023: Physiological Reports
https://read.qxmd.com/read/37918087/hyperandrogenism-drives-ovarian-inflammation-and-pyroptosis-a-possible-pathogenesis-of-pcos-follicular-dysplasia
#17
JOURNAL ARTICLE
Yu Xiang, Hua Wang, Huimin Ding, Tianyue Xu, Xiu Liu, Zichao Huang, Honghui Wu, Hongshan Ge
Hyperandrogenemia and persistent chronic inflammation, two main striking features of polycystic ovary syndrome (PCOS), have been proven involved in follicular dysgenesis in PCOS. However, the association between hyperandrogenism and inflammation activation in PCOS is not fully understood. Excess testosterone(T) induces inflammation and pyroptosis activation in a mouse model of PCOS, leading to ovarian dysfunction and fibrosis. Excessive endoplasmic reticulum (ER) stress is present in ovarian granulosa cells (GCs), testosterone-induced PCOS mouse and cellular models...
October 31, 2023: International Immunopharmacology
https://read.qxmd.com/read/37880791/the-effects-of-intermittent-fasting-diet-alone-or-in-combination-with-probiotic-supplementation-in-comparison-with-calorie-restricted-diet-on-metabolic-and-hormonal-profile-in-patients-with-polycystic-ovary-syndrome-study-protocol-for-a-randomized-clinical
#18
JOURNAL ARTICLE
Sepide Talebi, Sakineh Shab-Bidar, Hamed Mohammadi, Ashraf Moini, Kurosh Djafarian
INTRODUCTION: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in females characterized by ovulatory dysfunction, hyperandrogenism, and other metabolic disorders. Both intermittent fasting and specific probiotics have been suggested to help improve patients with PCOS through changes in gut microbial composition, circadian clock, and metabolic regulation. Therefore, the present study aims to investigate the effects of intermittent fasting alone or in combination with probiotic supplementation compared to the calorie-restricted (CR) diet on anthropometric measures, metabolic status, inflammation, and oxidative stress in women with PCOS...
October 25, 2023: Trials
https://read.qxmd.com/read/37715279/spiomet4health-efficacy-tolerability-and-safety-of-lifestyle-intervention-plus-a-fixed-dose-combination-of-spironolactone-pioglitazone-and-metformin-spiomet-for-adolescent-girls-and-young-women-with-polycystic-ovary-syndrome-study-protocol-for-a-multicentre
#19
JOURNAL ARTICLE
Cristina Garcia-Beltran, Rita Malpique, Marianne S Andersen, Firdevs Bas, Judit Bassols, Feyza Darendeliler, Marta Díaz, Barbara Dieris, Flaminia Fanelli, Elke Fröhlich-Reiterer, Alessandra Gambineri, Dorte Glintborg, Abel López-Bermejo, Christopher Mann, Silvia Marin, Barbara Obermayer-Pietsch, Rønnaug Ødegård, Pernille Ravn, Thomas Reinehr, Matteo Renzulli, Cristina Salvador, Viola Singer, Eszter Vanky, Juan Vicente Torres, Melek Yildiz, Francis de Zegher, Lourdes Ibáñez
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affecting 5-10% of AYAs worldwide. There is no approved pharmacological therapy for PCOS. Standard off-label treatment with oral contraceptives (OCs) reverts neither the underlying pathophysiology nor the associated co-morbidities. Pilot studies have generated new insights into the pathogenesis of PCOS, leading to the development of a new treatment consisting of a fixed, low-dose combination of two so-called insulin sensitisers [pioglitazone (PIO), metformin (MET)] and one mixed anti-androgen and anti-mineralocorticoid also acting as an activator of brown adipose tissue [spironolactone (SPI)], within a single tablet (SPIOMET)...
September 15, 2023: Trials
https://read.qxmd.com/read/37678489/anti-mullerian-hormone-a-marker-of-ovarian-reserve-is-protective-against-presence-and-severity-of-nash-in-premenopausal-women
#20
JOURNAL ARTICLE
Stephanie S Maldonado, Marcelle I Cedars, Katherine P Yates, Laura A Wilson, Ryan Gill, Norah A Terrault, Ayako Suzuki, Monika A Sarkar
BACKGROUND & AIMS: Anti-müllerian hormone (AMH) is a marker of ovarian reserve with emerging data linking lower levels to some metabolic and inflammatory diseases in women. Whether AMH levels influence nonalcoholic fatty liver disease (NAFLD) is unknown. METHODS: Leveraging the NASH Clinical Research Network we determined the association of AMH levels within 6 months of liver biopsy with presence and severity of histologic measures of NAFLD in premenopausal women...
September 5, 2023: Clinical Gastroenterology and Hepatology
keyword
keyword
29372
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.